Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD5024 1% Cream in Papulopustular Rosacea
NCT01494467Phase 3Completed
- Sponsor
- Galderma
- Start
- Dec 2011
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ivermectin in papulopustular rosacea, sponsored by Galderma. Started Dec 2011; status: completed.
02
Drugs
ivermectin
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on NCT01494467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01494467.